Experimental hepatitis b drug trial halted midway
NCT ID NCT02604212
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called ARC-520 in 32 adults with chronic hepatitis B who were already taking antiviral medications (entecavir or tenofovir). The goal was to see if adding ARC-520 could lower hepatitis B surface antigen levels more than placebo. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Hong Kong, 999077, China
-
Research Site 10
Leipzig, 04103, Germany
-
Research Site 11
Frankfurt, 60590, Germany
-
Research Site 12
Yangsan-si Gyeongnam, 626-770, South Korea
-
Research Site 13
Busan, 602-739, South Korea
-
Research Site 14
Seoul, 110-744, South Korea
-
Research Site 15
Incheon, 405-760, South Korea
-
Research Site 16
Seoul, 120-752, South Korea
-
Research Site 2
Hong Kong, China
-
Research Site 3
Tübingen, 72076, Germany
-
Research Site 4
Leipzig, 4103, Germany
-
Research Site 5
München, 81377, Germany
-
Research Site 6
Ulm, 89081, Germany
-
Research Site 7
Würzburg, 97080, Germany
-
Research Site 8
Hanover, 30625, Germany
-
Research Site 9
Hamburg, 20099, Germany